(#) Real-world usage of glucose lowering agents in heart failure patients with type 2 diabetes

被引：0
|
作者：
Martens, Pieter [1 ]
Janssens, Joyce [1 ]
Ramaekers, Jobbe [1 ]
Dupont, Matthias [1 ]
Mullens, Wilfried [1 ]
机构：
[1] Ziekenhuis Oost Limburg, Genk, Belgium
来源：
ACTA CARDIOLOGICA | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：63 / 64
页数：2
相关论文
共 50 条
  • [31] Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes
    Guo, Jingchuan
    Tang, Huilin
    Shao, Hui
    Lu, Ying
    Shi, Lizheng
    Fonseca, Vivian A.
    Cho, Hwayoung
    Guo, Yi
    Bian, Jiang
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5727 - 5736
  • [32] Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
    Funck, Kristian L.
    Knudsen, Jakob S.
    Hansen, Troels K.
    Thomsen, Reimar W.
    Grove, Erik L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 520 - 529
  • [33] FIBRATE USE IS ASSOCIATED WITH A LOWER INCIDENCE OF HEART FAILURE: A REAL-WORLD STUDY AMONG PEOPLE WITH TYPE 2 DIABETES
    Morieri, M. L.
    Rigato, M.
    Fagarazzi, C.
    Avogaro, A.
    Fadini, G. P.
    ATHEROSCLEROSIS, 2023, 379 : S191 - S191
  • [34] Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database
    Stoyanova, D.
    Stratmann, B.
    Schwandt, A.
    Heise, N.
    Muehldorfer, S.
    Ziegelasch, H-J
    Zimmermann, A.
    Tschoepe, D.
    Holl, R. W.
    DIABETIC MEDICINE, 2020, 37 (08) : 1291 - 1298
  • [35] Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study
    Radhika Nair
    Reema Mody
    Maria Yu
    Stuart Cowburn
    Manige Konig
    Todd Prewitt
    Diabetes Therapy, 2022, 13 : 1921 - 1932
  • [36] Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study
    Nair, Radhika
    Mody, Reema
    Yu, Maria
    Cowburn, Stuart
    Konig, Manige
    Prewitt, Todd
    DIABETES THERAPY, 2022, 13 (11-12) : 1921 - 1932
  • [37] Introduction: Real-World Evidence in Type 2 Diabetes
    Hassanein, Mohamed
    Amod, Aslam
    Khunti, Kamlesh
    Lee, Moon-Kyu
    Mohan, Viswanathan
    DIABETES THERAPY, 2020, 11 (SUPPL 2) : S29 - S32
  • [38] Introduction: Real-World Evidence in Type 2 Diabetes
    Mohamed Hassanein
    Aslam Amod
    Kamlesh Khunti
    Moon-Kyu Lee
    Viswanathan Mohan
    Diabetes Therapy, 2020, 11 : 29 - 32
  • [39] Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes: A retrospective, observational post-marketing study
    Shi, Chenyang
    Tan, Yijiong
    Hu, Shanshan
    Qin, Yingyi
    Tang, Yuanjun
    Wang, Yufan
    Fan, Guorong
    DIABETES OBESITY & METABOLISM, 2024, 26 (06): : 2513 - 2516
  • [40] Managing patients with heart failure: contemporary real-world experience
    Muhammad Siddiqui
    Christopher Ripplinger
    Hafsah Chalchal
    Dakshina Murthy
    BMC Research Notes, 15
12345